Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Halozyme focuses on developing and commercializing novel enzymatic therapies that target the tumor microenvironment or facilitate drug delivery. Our proprietary product, the ENHANZE™ drug delivery platform, supports strong, value-driving partnerships with leading pharmaceutical companies including Roche, Shire, Pfizer, Janssen, AbbVie and Lilly. The ENHANZE™ platform has sales in 50+ countries through three product approvals.